AstraZeneca Shareholders Vote in Favor of £19 Million CEO Pay

AstraZeneca Plc shareholders backed a pay increase for Pascal Soriot, who is already the highest paid chief executive officer of a company in the UK’s FTSE 100 stock index.

About two-thirds of investors on Thursday voted in favor of a new compensation policy that could result in Soriot earning more than 10 times his base salary in bonuses. His maximum annual pay for this year would increase to almost £19 million ($23.8 million) from £16.8 million.

The drugmaker faced a lower level of shareholder opposition than in 2021, when almost 40% of investors refused to support the remuneration policy for ...